Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Key Principal Partners (KPP) was a private equity firm headquartered in Cleveland, Ohio, that specialized in providing mezzanine debt and equity capital to middle-market companies. Affiliated with KeyCorp, the firm targeted investments in a broad range of sectors, including manufacturing, distribution, consumer products, and healthcare services. KPP typically provided flexible capital solutions for management buyouts, recapitalizations, and expansion strategies for companies with revenues between $30 million and $500 million. The firm was known for its ability to offer non-control equity and subordinated debt, allowing business owners to retain majority ownership while accessing growth capital. While it maintained a portfolio that included healthcare and medical technology companies, KPP operated as a financial institution rather than a life sciences research entity. The firm is no longer actively making new investments and has transitioned into a legacy portfolio management phase.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Key Principal Partners.